1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality : 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
Carlsson, Sigrid V ; Arnsrud Godtman, Rebecka ; Pihl, Carl-Gustav ; Vickers, Andrew ; Lilja, Hans LU
; Hugosson, Jonas
and Månsson, Marianne
LU
(2022)
In European Urology
- Contribution to journal › Article
- 2010
-
Mark
Impact of Recent Screening on Predicting the Outcome of Prostate Cancer Biopsy in Men With Elevated Prostate-Specific Antigen Data From the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden
Vickers, Andrew J. ; Cronin, Angel M. ; Aus, Gunnar ; Pihl, Carl-Gustav ; Becker, Charlotte LU ; Pettersson, Kim ; Scardino, Peter T. ; Hugosson, Jonas and Lilja, Hans LU
(2010)
In Cancer
116(11).
p.2612-2620
- Contribution to journal › Article
- 2008
-
Mark
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
Vickers, Andrew J. ; Cronin, Angel M. ; Aus, Gunnar ; Pihl, Carl-Gustav ; Becker, Charlotte LU ; Pettersson, Kim ; Scardino, Peter T. ; Hugosson, Jonas and Lilja, Hans LU
(2008)
In BMC Medicine
6.
- Contribution to journal › Article
- 2001
-
Mark
Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers
Hugosson, Jonas ; Lilja, Hans LU
; Lodding, Pär
and Pihl, Carl Gustav
(2001)
In European Urology
39(Suppl 4).
p.33-34
- Contribution to journal › Article